pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›oveporexton
drug · small molecule
save

oveporexton

pre_registrationupdated 5mo ago
by $TAK TAKEDA PHARMACEUTICAL CO LTD🔗 ChEMBL
community read0 votes

Small molecule drug.

all catalysts(0)

nothing on the calendar yet

Trials studying oveporexton

  • phase3A Study of TAK-861 for the Treatment of Narcolepsy Type 1completedn=168

News(3)

  • ‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing it
    As the hype around the vast medical potential of GLP-1 drugs continues unabated, another peptide is starting to make its own mark.
    fiercebiotech · 1mo ago
  • Takeda’s narcolepsy nod opens orexin doors
    Orzeyful is the first orexin agonist cleared by the FDA, and is the first narcolepsy therapy that addresses the full host of disease symptoms. It is "likely to reshape the treatment paradigm” for t…
    biospace · 1mo ago
  • FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
    The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
    fda_press · 1mo ago
generic
oveporexton
indication
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
phase
pre_registration
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 2h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?